December 16, 2013. When notorious and decades-known carcinogens such as asbestos and radon are still present at unsafe or unknown levels in American workplaces, how can the public have confidence that our regulations can handle new and complex occupational hazards arising every day?
Read More »We’re Speaking Out on Health Issues
NCHR scientists and health policy experts provide written and oral statements on a wide range of topics.
Here are many of the ways we have been Speaking Out on Health Policy Issues for the last few years. Whether the topic is legislation intended to cure diseases, proposed bans on BPA or other chemicals that disrupt your hormones, the importance of including women, people of color, and patients over 65 in clinical trials, or many other topics, you’ll gain a better understanding of our evidence-based analyses by reading these letters, statements, and testimony.
Here are the ways we have been Speaking out on Medical Treatments and Products, such as prescription drugs and medical devices that the FDA is considering approving, or is considering taking off the market because of serious risks. Whether the topic is Chantix, Addyi, Yaz, Essure, or medical products you’ve never heard of, you can find out more about what is known and not known about the safety and effectiveness of a wide range of products by looking through this section of our website.
NCHR Testimony on Classification of Stair-climbing and Mechanical Wheelchairs
December 12, 2013. Stair-climbing wheelchairs are have been considered high risk – Class III – and have been required to submit studies of safety and effectiveness under the PMA review process. The proposed order would reclassify stair-climbing wheelchairs into Class II indicating moderate risk, and reviewing it through the 510(k) process.
Read More »NCHR Testimony on Classification of Spinal Sphere Devices
December 12, 2013. For classification of spinal sphere devices, we support FDA in considering a Class III designation for these devices.
Read More »Letter in Support of the Whistleblower Protection Act
November 19, 2013. As members of the public health community, we write to urge you to support the Warner-Collins-Kaine-Grassley amendment to the National Defense Authorization Act for FY 2014 (NDAA, S. 1197).
Read More »NCHR Testimony on Premarket Approval of Nucleus Hybrid L24 System Cochlear Implants
November 8, 2013. Medical devices should not be approved on the basis of wishful thinking.
Read More »